Clinical trial
New Prognostic Kidney Function Markers in Emergency Patients
NCT02261909 is registered in ClinicalTrials.gov with Krankenhaus Barmherzige Brüder, Regensburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Prognostic Kidney Function Markers in Emergency Patients
- Lead sponsor
- Krankenhaus Barmherzige Brüder, Regensburg
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 31, 2015
- Completion date
- June 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, contrast media